Three-Year Clinical Outcomes With the Cilotax Dual Drug-Eluting Stent vs Everolimus-Eluting Stents in Patients With Acute Myocardial Infarction
CONCLUSION: In patients with acute myocardial infarction who underwent percutaneous coronary intervention, use of the Cilotax stent was associated with higher rates of target lesion revascularization, target vessel revascularization, and stent thrombosis than were everolimus-eluting stents. Use of the Cilotax dual drugeluting stent should be avoided in the treatment of myocardial infarction.PMID:38686684 | DOI:10.14503/THIJ-23-8271 (Source: Texas Heart Institute Journal)
Source: Texas Heart Institute Journal - April 30, 2024 Category: Cardiology Authors: HyeYon Yu Jihun Ahn Byoung Geol Choi Soohyung Park Dong Oh Kang Cheol Ung Choi Seung-Woon Rha Myung Ho Jeong Source Type: research
Three-Year Clinical Outcomes With the Cilotax Dual Drug-Eluting Stent vs Everolimus-Eluting Stents in Patients With Acute Myocardial Infarction
CONCLUSION: In patients with acute myocardial infarction who underwent percutaneous coronary intervention, use of the Cilotax stent was associated with higher rates of target lesion revascularization, target vessel revascularization, and stent thrombosis than were everolimus-eluting stents. Use of the Cilotax dual drugeluting stent should be avoided in the treatment of myocardial infarction.PMID:38686684 | DOI:10.14503/THIJ-23-8271 (Source: Texas Heart Institute Journal)
Source: Texas Heart Institute Journal - April 30, 2024 Category: Cardiology Authors: HyeYon Yu Jihun Ahn Byoung Geol Choi Soohyung Park Dong Oh Kang Cheol Ung Choi Seung-Woon Rha Myung Ho Jeong Source Type: research
Prognostic impact of heart failure admission in survivors of acute myocardial infarction
ConclusionsUtilizing real-world data of the contemporary percutaneous coronary intervention era from the Japan Acute Myocardial Infarction Registry database, this study demonstrates that the heart failure admission of AMI survivors was significantly associated with higher all-cause mortality rates. (Source: ESC Heart Failure)
Source: ESC Heart Failure - April 30, 2024 Category: Cardiology Authors: Satoshi Takeuchi,
Satoshi Honda,
Kensaku Nishihira,
Sunao Kojima,
Misa Takegami,
Yasuhide Asaumi,
Mike Saji,
Jun Yamashita,
Kiyoshi Hibi,
Jun Takahashi,
Yasuhiko Sakata,
Morimasa Takayama,
Tetsuya Sumiyoshi,
Hisao Ogawa,
Kazuo Kimura,
Satos Tags: Original Article Source Type: research
Impact of Polyvascular Disease in Patients undergoing unprotected Left Main Percutaneous Coronary Intervention
Percutaneous coronary intervention (PCI) has demonstrated its safety and efficacy in treating left main coronary artery disease (LM-CAD) in select patients. Polyvascular disease (PolyVD) is associated with adverse events in all-comers with CAD. However, there is little data examining the interplay between PolyVD and LM-PCI, which we sought to investigate in a retrospective single-center study. We included patients undergoing unprotected LM-PCI at a tertiary center from 2012-2019. The patient population was stratified based on the presence or absence of PolyVD (i.e. (Source: The American Journal of Cardiology)
Source: The American Journal of Cardiology - April 30, 2024 Category: Cardiology Authors: Benjamin Bay, Raman Sharma, Anastasios Roumeliotis, David Power, Samantha Sartori, Jonathan Murphy, Birgit Vogel, Kenneth F Smith, Angelo Oliva, Amit Hooda, Joseph Sweeny, George Dangas, Annapoorna Kini, Prakash Krishnan, Samin K Sharma, Roxana Mehran Source Type: research
A Simple Bleeding Risk Score for the Complex Elderly Patient
Coronary artery disease (CAD) is a leading global cause of death worldwide, and in an aging society, the burden of percutaneous coronary intervention (PCI) in the elderly population is increasing.(1) An important feature that distinguishes this cohort is the significant increase in the likelihood of experiencing bleeding and ischemic events.(2) Given the comparable prognostic significance of both bleeding and ischemic events(3), the selection of the appropriate intensity and duration of antiplatelet therapy assumes a crucial role from a clinical perspective. (Source: The American Journal of Cardiology)
Source: The American Journal of Cardiology - April 30, 2024 Category: Cardiology Authors: Fiorenzo Simonetti, Adnan Kastrati Tags: Editorial Source Type: research
Impact of Sex Differences on Clinical Outcomes in Patients Following Primary Revascularization for Acute Myocardial Infarction - Insights From the Japanese Nationwide Registry
CONCLUSIONS: Within this nationwide cohort, women had worse clinical outcomes following AMI than men. However, these sex-related differences in outcomes diminished after adjusting for age. In addition, CKD was significantly associated with all-cause mortality in both sexes.PMID:38684394 | DOI:10.1253/circj.CJ-23-0966 (Source: Circulation Journal)
Source: Circulation Journal - April 29, 2024 Category: Cardiology Authors: Tomoya Hoshi Mitsuaki Sawano Shun Kohsaka Hideki Ishii Tetsuya Amano Toshiharu Takeuchi Jun Takahashi Daigo Hiraya Hiroaki Watabe Tomoko Ishizu Ken Kozuma Source Type: research
Impact of Sex Differences on Clinical Outcomes in Patients Following Primary Revascularization for Acute Myocardial Infarction - Insights From the Japanese Nationwide Registry
CONCLUSIONS: Within this nationwide cohort, women had worse clinical outcomes following AMI than men. However, these sex-related differences in outcomes diminished after adjusting for age. In addition, CKD was significantly associated with all-cause mortality in both sexes.PMID:38684394 | DOI:10.1253/circj.CJ-23-0966 (Source: Circulation Journal)
Source: Circulation Journal - April 29, 2024 Category: Cardiology Authors: Tomoya Hoshi Mitsuaki Sawano Shun Kohsaka Hideki Ishii Tetsuya Amano Toshiharu Takeuchi Jun Takahashi Daigo Hiraya Hiroaki Watabe Tomoko Ishizu Ken Kozuma Source Type: research
Differential Use of Glycoprotein IIb/IIIa Inhibitors with Bivalirudin in Patients with STEMI Undergoing PCI: A Systematic Review and Meta-Analysis
ConclusionOverall, our findings suggest that bivalirudin may be a more efficacious intervention than heparin for reducing certain adverse events in patients with STEMI undergoing primary PCI. (Source: American Journal of Cardiovascular Drugs)
Source: American Journal of Cardiovascular Drugs - April 29, 2024 Category: Cardiology Source Type: research
Predictive Value of 5-Methoxytryptophan on Long-Term Clinical Outcome after PCI in Patients with Acute Myocardial Infarction-a Prospective Cohort Study
ConclusionsPlasma 5-MTP is an independent and protective early biomarker for 1-year MACE and HF events in patients with AMI, especially in younger patients and those with T2DM, STEMI, and baseline HFpEF characteristics.Graphical Abstract (Source: Journal of Cardiovascular Translational Research)
Source: Journal of Cardiovascular Translational Research - April 29, 2024 Category: Cardiology Source Type: research
The relationship between levels of tumor necrosis factor-alpha, interleukin-6, and C-reactive protein in the serum of elderly and acute myocardial infarction
This study aimed to explore the relationship between the serum levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and hypersensitive C-reactive protein (hs-CRP) and the prognosis of acute myocardial infarction (AMI) patients after percutaneous coronary intervention (PCI) treatment. A total of 118 early-onset AMI patients who successfully received PCI (in the PCI group, blood samples were collected before PCI, 12, 24, 48 h after PCI, and 90 d follow-up period) and 52 AMI patients who received only cardioangiography (CAG) (in the CAG group, blood samples were collected before CAG, 12, 24, 48 h after CAG, and 9...
Source: Mol Biol Cell - April 28, 2024 Category: Molecular Biology Authors: Jinlong Miao Tao Du Source Type: research
Drug-coated balloon in the treatment of coronary artery de-novo large lesions angiography
Cell Mol Biol (Noisy-le-grand). 2024 Apr 28;70(4):196-201. doi: 10.14715/cmb/2024.70.4.31.ABSTRACTThe superiority of drug-coated balloon (DCB) in treating small vessels, branching lesions, and high-risk bleeding lesions in coronary heart disease patients has been confirmed. However, its safety and efficacy in large vessels are still unclear. We aimed to investigate whether the efficacy of DCB in large vessels is not inferior to that of drug-eluting stent (DES). From November 2019 to April 2022, a total of 88 patients in our hospital who underwent coronary angiography for the first time and decided to receive DCB or DES tre...
Source: Mol Biol Cell - April 28, 2024 Category: Molecular Biology Authors: Xingyou Cai Xin Hong Yuli Wang Yafei Li Guidong Xu Source Type: research
Drug-coated balloon in the treatment of coronary artery de-novo large lesions angiography
Cell Mol Biol (Noisy-le-grand). 2024 Apr 28;70(4):196-201. doi: 10.14715/cmb/2024.70.4.31.ABSTRACTThe superiority of drug-coated balloon (DCB) in treating small vessels, branching lesions, and high-risk bleeding lesions in coronary heart disease patients has been confirmed. However, its safety and efficacy in large vessels are still unclear. We aimed to investigate whether the efficacy of DCB in large vessels is not inferior to that of drug-eluting stent (DES). From November 2019 to April 2022, a total of 88 patients in our hospital who underwent coronary angiography for the first time and decided to receive DCB or DES tre...
Source: Cellular and Molecular Biology - April 28, 2024 Category: Molecular Biology Authors: Xingyou Cai Xin Hong Yuli Wang Yafei Li Guidong Xu Source Type: research
The relationship between levels of tumor necrosis factor-alpha, interleukin-6, and C-reactive protein in the serum of elderly and acute myocardial infarction
This study aimed to explore the relationship between the serum levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and hypersensitive C-reactive protein (hs-CRP) and the prognosis of acute myocardial infarction (AMI) patients after percutaneous coronary intervention (PCI) treatment. A total of 118 early-onset AMI patients who successfully received PCI (in the PCI group, blood samples were collected before PCI, 12, 24, 48 h after PCI, and 90 d follow-up period) and 52 AMI patients who received only cardioangiography (CAG) (in the CAG group, blood samples were collected before CAG, 12, 24, 48 h after CAG, and 9...
Source: Cellular and Molecular Biology - April 28, 2024 Category: Molecular Biology Authors: Jinlong Miao Tao Du Source Type: research
Drug-coated balloon in the treatment of coronary artery de-novo large lesions angiography
Cell Mol Biol (Noisy-le-grand). 2024 Apr 28;70(4):196-201. doi: 10.14715/cmb/2024.70.4.31.ABSTRACTThe superiority of drug-coated balloon (DCB) in treating small vessels, branching lesions, and high-risk bleeding lesions in coronary heart disease patients has been confirmed. However, its safety and efficacy in large vessels are still unclear. We aimed to investigate whether the efficacy of DCB in large vessels is not inferior to that of drug-eluting stent (DES). From November 2019 to April 2022, a total of 88 patients in our hospital who underwent coronary angiography for the first time and decided to receive DCB or DES tre...
Source: Mol Biol Cell - April 28, 2024 Category: Molecular Biology Authors: Xingyou Cai Xin Hong Yuli Wang Yafei Li Guidong Xu Source Type: research
